// Migrated from Contentful resource "where-is-the-data-the-healthcare-data-you-need-to-drive-commercialization" (Gatsby node 0a4d9fe4-080a-5c0b-94fe-560974b49038) on 2026-10-13.
// Source: https://phil.us/page-data/where-is-the-data-the-healthcare-data-you-need-to-drive-commercialization/page-data.json
import React from "react";
import type { HeadFC } from "gatsby";
import { SeoMeta } from "components/common/Seo/SeoMeta";
import { JsonLd } from "components/common/Seo/JsonLd";
import { articleSchema } from "utils/seo/schema";
import { StaticBlogLayout, BlogA, BlogH2, BlogLI, BlogOL, BlogP, BlogUL } from "components/Blog/StaticBlogLayout/StaticBlogLayout";

const PATH = "/where-is-the-data-the-healthcare-data-you-need-to-drive-commercialization/";
const TITLE = "Where's the Data? The Healthcare Data You Need to Drive Commercialization";
const DESCRIPTION = "Pharma companies that make data-informed commercialization decisions will realize better business outcomes and a competitive advantage.";
const OG_IMAGE = "https://phil.us/images/blog/og/6-Company_News.webp";

export const Head: HeadFC = () => (
  <>
    <SeoMeta title={TITLE} description={DESCRIPTION} path={PATH} type="article" image={OG_IMAGE} />
    <JsonLd data={articleSchema({ path: PATH, headline: TITLE, description: DESCRIPTION, image: OG_IMAGE })} />
  </>
);

const Page: React.FC = () => (
  <StaticBlogLayout title={TITLE} hero={{ src: "/images/blog/6-Company_News.svg", alt: "" }}>
    <BlogP>{"What matters most for life sciences companies is not the amount of data but knowing how to use it. A "}<BlogA href="https://www.forrester.com/report/InsightsDriven-Businesses-Set-The-Pace-For-Global-Growth/RES130848">Forrester report</BlogA>{" revealed that data-driven companies experience an annual average growth rate of over 30%. Pharma companies that invest in capabilities to capture and analyze the best data to make informed commercialization decisions will realize better business outcomes and a competitive advantage."}</BlogP>
    <BlogH2><b>{"Understanding the value of data "}</b></BlogH2>
    <BlogP>{"Data alone hold negligible value because it reveals very little meaningful information. The true value of data comes from analyzing the data to enable actionable insights. These insights can help pharma companies "}<BlogA href="/leveraging-data-analytics/">boost market access</BlogA>{", improve business operations, and strengthen customer relationships. Using a data-driven approach for pharma commercialization can "}<BlogA href="https://www.mckinsey.com/industries/life-sciences/our-insights/how-pharma-can-accelerate-business-impact-from-advanced-analytics">generate substantial returns</BlogA>{", including a 5-10 percent net revenue improvement and 10-20 percent spend reduction/reallocation. "}</BlogP>
    <BlogP>By basing decisions on accurate information backed by validated data, pharma companies avoid moving in the wrong direction. Data-supported decisions eliminate political influence, bias, and following “gut feelings” that can lead to poor decision-making and waste valuable resources.</BlogP>
    <BlogP>Not all data is equal in its ability to contribute to sound business decisions. Data must be current and accurate when decisions are made. The healthcare environment is constantly evolving, so pharma companies should not rely on initial data sets that are likely to be no longer relevant. Continually collecting and analyzing data is key to effective commercialization strategies.</BlogP>
    <BlogP>Data sources for pharmaceutical commercialization</BlogP>
    <BlogP>{"There are various sources from which commercialization teams can leverage real-world data – post-launch data collected outside of a clinical trial – to make strategic, informed decisions, including: "}</BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Electronic health records (EHRs) and e-prescribing systems</b></BlogP>
        <BlogP>contain current, accurate patient-based data from prescribers.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Retail pharmacies</b></BlogP>
        <BlogP>collect a wide range of data on the prescriptions they fill and dispense, which offer a clearer picture of a patient’s medication use and barriers to adherence.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Supply-chain operations</b></BlogP>
        <BlogP>{"generate data across the entire "}<BlogA href="/pharma-product-mid-life-cycle-risk/">product lifecycle</BlogA>, which can help identify vulnerabilities and bottlenecks that negatively impact market access.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Payer claims</b></BlogP>
        <BlogP>can provide medical claims data and data around enrollment and engagement in health plans and optional programs.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Patient-reported outcomes</b></BlogP>
        <BlogP>data comes from surveys in which patients independently report the status of their health conditions during treatment.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Digital devices and mobile health applications</b></BlogP>
        <BlogP>contain a wealth of patient-generated data on health habits and disease outcomes.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Disease registries</b></BlogP>
        <BlogP>collect data on patient populations diagnosed with specific conditions, which may reveal the quality of life and financial burden issues as well as other challenges not found in EHRs.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogP><br /></BlogP>
    <BlogUL>
      <BlogLI>
        <BlogP><b>Customer relationship management (CRM) systems</b></BlogP>
        <BlogP>provide customer, customer engagement, and sales activity data that can drive commercialization objectives.</BlogP>
      </BlogLI>
    </BlogUL>
    <BlogH2>{"\n"}<b>{"11 data-driven opportunities for pharmaceutical commercialization "}</b></BlogH2>
    <BlogP>{"Data-driven decision-making offers many opportunities for pharmaceutical commercialization teams, including the ability to: "}</BlogP>
    <BlogOL>
      <BlogLI>
        <BlogP><br /><BlogA href="/does-your-pharmaceutical-brands-data-demonstrate-value-to-payers/">Demonstrate the value</BlogA>{" of treatments to payers"}</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Enable outcomes-based pricing</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>{"Achieve a "}<BlogA href="/market-access-strategy-drug-formulary/">better formulary position</BlogA><br /></BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>{"Drive "}<BlogA href="/advancing-medication-adherence-with-data-driven-interventions/">medication adherence</BlogA><br /></BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Identify new opportunities for existing brands</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>{"Inform the "}<BlogA href="/how-to-choose-the-best-commercialization-partner-to-drive-patient-access/">design of patient services</BlogA><br /></BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Identify underdiagnosed patients</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Grow sales and improve processes</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Develop point-of-care clinical decision support</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>Strengthen provider, payer, and patient engagement</BlogP>
      </BlogLI>
      <BlogLI>
        <BlogP>{"Harness the full "}<BlogA href="/life-science-company-digital-technology/">power of digital technology</BlogA>{" investments"}</BlogP>
      </BlogLI>
    </BlogOL>
    <BlogH2><b>Unlocking the power of data</b></BlogH2>
    <BlogP>{"Unlocking the power of data should be at the forefront of pharmaceutical manufacturers’ efforts to align business goals and outcomes. Faced with an overwhelming amount of data and a complex healthcare ecosystem, many pharma commercialization teams find that getting a holistic – and timely – view of stakeholders is a significant hurdle. Data analytics can help companies quickly respond and adapt to market changes and obtain a competitive advantage with the right commercialization partner. "}</BlogP>
    <BlogP>{"Phil is an end-to-end commercialization partner that provides an integrated approach to data analytics across the patient journey giving life science commercialization teams real-time visibility and control over their distribution channels. "}<BlogA href="/pharma/">Get in touch today</BlogA>{" to discover how you can drive market access with deeper data insights.   "}</BlogP>
  </StaticBlogLayout>
);

export default Page;
